Back to top
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Best Momentum Stocks to Buy for January 4th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 4th:
ImmunoGen, Inc. : This commercial-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 250% over the last 60 days.
ImmunoGen, Inc. Price and Consensus
ImmunoGen, Inc. price-consensus-chart | ImmunoGen, Inc. Quote
ImmunoGen’s shares gained 88.4% over the last three months compared with the S&P 500’s advance of 10.7%. The company possesses a Momentum Score of B.
ImmunoGen, Inc. Price
ImmunoGen, Inc. price | ImmunoGen, Inc. Quote
GitLab Inc. (GTLB - Free Report) : This software development company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 285.71% over the last 60 days.
GitLab Inc. Price and Consensus
GitLab Inc. price-consensus-chart | GitLab Inc. Quote
Gitlab’s shares gained 31% over the last three months compared with the S&P 500’s advance of 10.7%. The company possesses a Momentum Score of B.
GitLab Inc. Price
GitLab Inc. price | GitLab Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.